Bank of New York Mellon Portfolio holdings
Bank of New York Mellon (BNY Mellon), tracing its origins to 1784 when Alexander Hamilton founded the Bank of New York, is a global financial institution headquartered in New York City, specializing in asset servicing, custody banking, and investment management. As one of the world’s largest custodian banks, it safeguards trillions in assets for institutions like pension funds, mutual funds, and governments, while its investment arm manages billions through subsidiaries like Mellon Investments and Dreyfus. Known for its role as a financial infrastructure backbone, BNY Mellon also provides treasury services, wealth management, and market analytics, blending a rich historical legacy with modern fintech innovations. The 2007 merger of Bank of New York and Mellon Financial solidified its position as a leader in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
BMOP
BNY Mellon Municipal Opportunities ETF
BMOP
|
+$1.73B |
| 2 |
BKMI
BNY Mellon Municipal Intermediate ETF
BKMI
|
+$1.63B |
| 3 |
AstraZeneca
AZN
|
+$1.19B |
| 4 |
Texas Instruments
TXN
|
+$836M |
| 5 |
FITB
Fifth Third Bancorp
FITB
|
+$744M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$2.06B |
| 2 |
Apple
AAPL
|
+$1.49B |
| 3 |
Microsoft
MSFT
|
+$1.16B |
| 4 |
Bank of America
BAC
|
+$859M |
| 5 |
TSMC
TSM
|
+$824M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.98% |
| 2 | Financials | 11.85% |
| 3 | Healthcare | 10.11% |
| 4 | Industrials | 9.34% |
| 5 | Consumer Discretionary | 8.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1851
Dime Commercial Bancshares
DCOM
$1.81B
| $11.7M | ﹤0.01% |
346,673
-10,606
| -3% | -$348K |
|
1852
FMC
FMC
$1.27B
| $11.7M | ﹤0.01% |
678,795
+78,760
| +13% | +$1.18M |
|
1853
AB High Yield ETF
HYFI
$331M
| $11.6M | ﹤0.01% |
313,132
-4,899
| -2% | -$184K |
|
1854
Franklin Dynamic Municipal Bond ETF
FLMI
$2.36B
| $11.6M | ﹤0.01% |
469,030
+93,595
| +25% | +$2.35M |
|
1855
Neogen
NEOG
$2.54B
| $11.6M | ﹤0.01% |
1,246,638
-47,640
| -4% | -$469K |
|
1856
Global Net Lease
GNL
$1.85B
| $11.6M | ﹤0.01% |
1,236,376
-42,224
| -3% | -$397K |
|
1857
Rogers Corp
ROG
$2.55B
| $11.6M | ﹤0.01% |
107,777
-2,777
| -3% | -$286K |
|
1858
DXP Enterprises
DXPE
$3.12B
| $11.5M | ﹤0.01% |
82,303
-3,202
| -4% | -$429K |
|
1859
CoreCivic
CXW
$3.25B
| $11.5M | ﹤0.01% |
606,141
-50,021
| -8% | -$943K |
|
1860
Scholar Rock
SRRK
$6.4B
| $11.4M | ﹤0.01% |
232,672
+654
| +0.3% | +$29.3K |
|
1861
HCI Group
HCI
$2.29B
| $11.4M | ﹤0.01% |
73,972
-977
| -1% | -$160K |
|
|
PSKY
1862
Paramount Skydance Corp
PSKY
$11.4B
| $11.4M | ﹤0.01% |
1,266,653
-224,623
| -15% | -$2.46M |
|
1863
Vanguard Morningstar Mega Cap Growth ETF
MGK
$33.9B
| $11.4M | ﹤0.01% |
155,465
+1,895
| +1% | +$149K |
|
1864
State Street SPDR Portfolio Intermediate Term Corporate Bond ETF
SPIB
$11.5B
| $11.4M | ﹤0.01% |
340,603
+152,530
| +81% | +$5.15M |
|
1865
Innoviva
INVA
$1.53B
| $11.4M | ﹤0.01% |
489,497
+6,464
| +1% | +$139K |
|
1866
Lemonade
LMND
$4.07B
| $11.4M | ﹤0.01% |
181,510
-4,133
| -2% | -$286K |
|
1867
Amneal Pharmaceuticals
AMRX
$6.32B
| $11.4M | ﹤0.01% |
914,089
+418,241
| +84% | +$5.62M |
|
|
XHR
1868
Xenia Hotels & Resorts
XHR
$1.77B
| $11.4M | ﹤0.01% |
765,705
-1,777
| -0.2% | -$26.8K |
|
1869
Interface
TILE
$2.19B
| $11.3M | ﹤0.01% |
454,521
-7,721
| -2% | -$231K |
|
1870
Acadia Healthcare
ACHC
$2.87B
| $11.3M | ﹤0.01% |
483,950
+8,790
| +2% | +$159K |
|
1871
CG Oncology
CGON
$6.65B
| $11.3M | ﹤0.01% |
167,030
+11,874
| +8% | +$673K |
|
1872
LiveRamp
RAMP
$2.3B
| $11.3M | ﹤0.01% |
425,582
-36,990
| -8% | -$969K |
|
1873
Adient
ADNT
$1.57B
| $11.3M | ﹤0.01% |
557,963
-30,023
| -5% | -$668K |
|
1874
RPC Inc
RES
$1.41B
| $11.3M | ﹤0.01% |
1,591,663
+10,075
| +0.6% | +$62.8K |
|
1875
Fidelity Enhanced Mid Cap Core ETF
FMDE
$8.25B
| $11.2M | ﹤0.01% |
312,508
+67,438
| +28% | +$2.5M |
|
Similar funds
Bank of New York Mellon's Q1 2026 Portfolio in Review
As of Q1 2026, Bank of New York Mellon held 4,358 positions worth $544B, down 4.2% from $568B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Bank of New York Mellon's Q1 2026 filing shows 177 new, 1,536 increased, 2,374 reduced and 164 closed positions. Its largest new stake was BNY Mellon Municipal Opportunities ETF: 69,304,856 shares worth $1.71B. The largest sale was Vanguard S&P 500 ETF, an estimated $2.06B.
By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 28% a quarter earlier, followed by Financials and Healthcare.
- Bank of New York Mellon's largest Q1 2026 buy was BNY Mellon Municipal Opportunities ETF: 69,304,856 shares worth $1.71B.
- Bank of New York Mellon added most to AstraZeneca in Q1 2026, an estimated $1.19B increase.
- Bank of New York Mellon's biggest Q1 2026 reduction was Vanguard S&P 500 ETF, cutting an estimated $2.06B.
- Bank of New York Mellon fully exited Comerica in Q1 2026, selling an estimated $293M.
- Bank of New York Mellon's ten largest holdings make up 25% of its $544B portfolio in Q1 2026.
- Bank of New York Mellon opened 177 new positions and closed 164 in Q1 2026.
- Bank of New York Mellon's portfolio value fell 4.2% quarter-over-quarter to $544B.
Based on Bank of New York Mellon's 13F filing for Q1 2026, filed 5 May 2026.